Oropharyngeal HPV-positive tumours frequently harbour a downregulation of TP53/p53 (due to inactivation and degradation by the major viral oncoprotein E6), and exhibit increased p16 expression (due to the suppression of retinoblastoma protein [pRb] by E7, with cell cycle arrest and p16 accumulation) [4,150]. The gene discussed is TP53; the disease is neoplasm.